Identification of oral candidosis, hairy leukoplakia and recurrent oral ulcers as distinct cases of immune reconstitution inflammatory syndrome

International Journal of STD and AIDS

Volumn 20, Issue 4, 2009, Pages 259-261

  Ramirez Amador V A ^a,c   Espinosa, E ^b   Gonzalez Ramirez I ^a   Anaya Saavedra, G ^a   Ormsby, C E ^b   Reyes Teran G ^b  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^c NONE   (Mexico)

Author keywords

AIDS; HAART; Immune reconstitution; Opportunistic infections; Oral lesions

Indexed keywords

ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MOUTH DISEASE; MOUTH LESION; MOUTH ULCER; PRIORITY JOURNAL; SYMPTOM; T LYMPHOCYTE; THRUSH; VIROTHERAPY; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; CANDIDIASIS, ORAL; COHORT STUDIES; DIAGNOSIS, ORAL; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEUKOPLAKIA, HAIRY; ORAL ULCER; TREATMENT FAILURE;

EID: 66349113581     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008351     Document Type: Article

References (14)

1. Manabe YC, Campbell JD, Sydnor E, Moore RD. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007;46:456-462 (Pubitemid 350098697)
2. Classification and diagnostic criteria for oral lesions in HIV Infection. EC-clearinghouse on oral problems related to HIV infection and WHO collaborating centre on oral manifestations of the immunodeficiency virus. J Oral Pathol Med 1993;22:289-291
3. Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the Use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, 2008; pp 1-139. www.aidsinfo.nih.gov/ ContentFiles/AdultandAdolescentGL.pdf. November 2008 (last accessed 17 February 2009)
4. Phillips P, Bonner S, Gataric N, et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin Infect Dis 2005;41:1483-1497 (Pubitemid 41579994)
5. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005;19:399-406 (Pubitemid 40446186)
6. Chattopadhyay A, Caplan DJ, Slade DG, Shugars DC, Tien HC, Patton LL. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults. Community Dent Oral Epidemiol 2005;33:35-44 (Pubitemid 41638657)
7. Campo J, Del RJ, Castilla J, Garcia S, Rodriguez C, Bascones A. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. J Oral Pathol Med 2002;31:5-10 (Pubitemid 34535942)
8. MacPhail LA, Komaroff E, Alves ME, Navazesh M, Phelan JA, Redford M. Differences in risk factors among clinical types of oral candidiasis in the Women's Interagency HIV Study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:45-55 (Pubitemid 41158127)
9. Lifson AR, Hilton JF, Westenhouse JL, et al. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 1994;8:73-79 (Pubitemid 24094091)
10. Moura MD, Grossmann SM, Fonseca LM, Senna MI, Mesquita RA. Risk factors for oral hairy leukoplakia in HIV-infected adults of Brazil. J Oral Pathol Med 2006;35:321-326 (Pubitemid 43876214)
11. Feller L, Anagnostopoulos C, Wood NH, Bouckaert M, Raubenheimer EJ, Lemmer J. Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report. J Periodontol 2008;79:362-368
12. Domingo P, Torres OH, Ris J, Vasques G. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. Am J Med 2001;110:605-609 (Pubitemid 32510686)
13. Martinez E, Gatell J, Morán Y, et al. High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis 1998;27:1510-1513 (Pubitemid 29242429)
14. Ramírez-Amador V, Ponce-de-León S, Anaya-Saavedra G, Crabtree Ramírez B, Sierra-Madero J. Oral lesions as clinical markers of HAART failure: a nested case-control study in Mexico City. Clin Infect Dis 2007;45:925-932